Benjamin Mordmüller
Benjamin Mordmüller
Verified email at uni-tuebingen.de
TitleCited byYear
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
RTS, S Clinical Trials Partnership
New England Journal of Medicine 367 (24), 2284-2295, 2012
870*2012
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
773*2011
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
3092016
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria
JFJ Kun, B Mordmüller, B Lell, LG Lehman, D Luckner, PG Kremsner
The Lancet 351 (9098), 265-266, 1998
2111998
Nitric Oxide Synthase 2Lambaréné (G‐954C), Increased Nitric Oxide Production, and Protection against Malaria
JF Kun, B Mordmüller, DJ Perkins, J May, O Mercereau‐Puijalon, ...
The Journal of infectious diseases 184 (3), 330-336, 2001
1992001
Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-γ-mediated effect
OA Skorokhod, M Alessio, B Mordmüller, P Arese, E Schwarzer
The Journal of Immunology 173 (6), 4066-4074, 2004
1802004
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ...
Nature 542 (7642), 445, 2017
1732017
Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism
B Mordmüller, D Krappmann, M Esen, E Wegener, C Scheidereit
EMBO reports 4 (1), 82-87, 2003
1622003
The IκB kinase complex and NF-κB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1
D Krappmann, E Wegener, Y Sunami, M Esen, A Thiel, B Mordmuller, ...
Molecular and cellular biology 24 (14), 6488-6500, 2004
1512004
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
1462014
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies
MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ...
Journal of Experimental Medicine 210 (2), 389-399, 2013
1432013
Selection of a trioxaquine as an antimalarial drug candidate
F Coslédan, L Fraisse, A Pellet, F Guillou, B Mordmüller, PG Kremsner, ...
Proceedings of the National Academy of Sciences 105 (45), 17579-17584, 2008
1362008
Malaria pigment in leucocytes
WG Metzger, BG Mordmüller, PG Kremsner
Transactions of the Royal Society of Tropical Medicine and Hygiene 89 (6 …, 1995
1201995
Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate
M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ...
Vaccine 27 (49), 6862-6868, 2009
1152009
Notch ligands Delta‐like1, Delta‐like4 and Jagged1 differentially regulate activation of peripheral T helper cells
S Rutz, B Mordmüller, S Sakano, A Scheffold
European journal of immunology 35 (8), 2443-2451, 2005
1112005
Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance.
BG Mordmüller, WG Metzger, P Juillard, BM Brinkman, CL Verweij, ...
European cytokine network 8 (1), 29-35, 1997
1031997
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
TL Richie, PF Billingsley, BKL Sim, ER James, S Chakravarty, JE Epstein, ...
Vaccine 33 (52), 7452-7461, 2015
1022015
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults
JL Grogan, PG Kremsner, GJ van Dam, W Metzger, B Mordmüller, ...
Journal of Infectious Diseases 173 (5), 1242-1247, 1996
1011996
Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon
A Kreidenweiss, PG Kremsner, B Mordmüller
Malaria journal 7 (1), 187, 2008
992008
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
M Ramharter, F Kurth, AC Schreier, J Nemeth, I von Glasenapp, S Bélard, ...
The Journal of infectious diseases 198 (6), 911-919, 2008
872008
The system can't perform the operation now. Try again later.
Articles 1–20